The Global Metabolism Drugs Market Size Was Valued at USD 8.0 Billion in 2023 and is Projected to Reach USD 13.8 Billion by 2032, Growing at a CAGR of 6.3% From 2024-2032. The Metabolism Drugs market encompasses a broad range of pharmaceutical agents designed to treat metabolic disorders, which are conditions that disrupt the body's normal chemical processes. These disorders include diabetes,...